- Filed
- Aug 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 14, 2024 | 313.97K sh |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $15.51M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $13.8M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $17.25M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $15.45M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $132.43K |
| Current Assets | Q2 2024 · Dec 31, 2023 | $423.81K |
| Total Assets | Q2 2024 · Jun 30, 2024 | $6.57M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $7.45M |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 47.52K sh |
| Shares Diluted restated | Q2 2024 · Jun 30, 2023 | 27.37K sh |
| Capex | Q2 2024 · Jun 30, 2023 | $167.43K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | $175.92K |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | −$8.5M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | −$9.16M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | −$8.77M |
| Eps Diluted restated | Q2 2024 · Jun 30, 2023 | $1.88 |
| Eps Diluted restated | Q2 2024 · Jun 30, 2023 | −$23.69 |
| Eps Basic restated | Q2 2024 · Jun 30, 2023 | $1.88 |
| Eps Basic restated | Q2 2024 · Jun 30, 2023 | −$23.69 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $1.64M |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $3.04M |
| Net Income | Q2 2024 · Jun 30, 2023 | $89.54K |
| Net Income | Q2 2024 · Jun 30, 2023 | −$648.35K |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$1.33M |
| Operating Income | Q2 2024 · Jun 30, 2023 | −$1.59M |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $374.16K |
| Gross Profit | Q2 2024 · Jun 30, 2023 | $1.54M |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $244.88K |
| Cost Of Revenue | Q2 2024 · Jun 30, 2023 | $453.86K |
| Revenue | Q2 2024 · Jun 30, 2023 | $619.04K |
| Revenue | Q2 2024 · Jun 30, 2023 | $2M |